Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. (Record no. 27445887)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02129 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517165938.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201804s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1420-3049 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.3390/molecules22081265 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mezeiova, Eva |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180423 |
| 245 00 - TITLE STATEMENT | |
| Title | Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Molecules (Basel, Switzerland) |
| Date of publication, distribution, etc. | Jul 2017 |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acetylcholinesterase |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Alzheimer Disease |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aminoquinolines |
| General subdivision | chemical synthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Binding Sites |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Blood-Brain Barrier |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Butyrylcholinesterase |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Catalytic Domain |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Survival |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cholinesterase Inhibitors |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Design |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Discovery |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enzyme Activation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heterocyclic Compounds, 4 or More Rings |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hydrolysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Inhibitory Concentration 50 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Models, Molecular |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Conformation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Structure |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Permeability |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Binding |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Structure-Activity Relationship |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tacrine |
| General subdivision | analogs & derivatives |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Korabecny, Jan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sepsova, Vendula |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hrabinova, Martina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jost, Petr |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Muckova, Lubica |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kucera, Tomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dolezal, Rafael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Misik, Jan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spilovska, Katarina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pham, Ngoc Lam |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pokrievkova, Lucia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roh, Jaroslav |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jun, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soukup, Ondrej |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaping, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kuca, Kamil |
| 773 0# - HOST ITEM ENTRY | |
| Title | Molecules (Basel, Switzerland) |
| Related parts | vol. 22 |
| -- | no. 8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.3390/molecules22081265">https://doi.org/10.3390/molecules22081265</a> |
| Public note | Available from publisher's website |
No items available.